Bluejay Investor Presentation Deck

Financial Highlights Financial Info (June 30, 2022) Cash* Est. Cash Runway ●●● $15.3MM Clean Balance Sheet BJDX (NASDAQ) (June 30, 2022) Market Capitalization Average daily trading volume Shares outstanding bluejay DIAGNOSTICS Beyond the date of anticipated approval and initial commercialization of the Symphony IL-6 Test No outstanding warrants or debt $21.3MM 980K shares 20.1 MM *Cash is comprised of cash, cash equivalents and investments, per the Q2 2022 10Q filing. Warrants based on Q2:22 Balance Sheet Symphony Sympheny bluejay bluejay Sympheny Low- Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | September 2022 14

View entire presentation